Directors of the California stem cell agency last week handed out $2 million a minute to nearly 20 organizations during an online meeting that spread the largess from Sacramento in the north to San Diego in the south.
All but one of the awards went to institutions that have or had ties to members of the governing board of what is known officially as the California Institute for Regenerative Medicine (CIRM).Its total cost to taxpayers is estimated to be about $12 billion.
The situation is nothing new for CIRM, which was designed in 2004 to give nearly all the Golden States stem cell research organizations a seat at the table where the money is handed out.
In slightly more than 47 minutes, the directors rubber-stamped the earlier de facto decisions on the $98 million in grant applications
Since CIRMs inception, 80 percent of the awards $2.7 billion has gone to organizations with links to board members,according to an analysis by theCalifornia Stem Cell Report. And it is all legal, courtesy of the states ballot initiative process.
Last weeks session involved training grants for graduate students. A few years back the program was terminated because of a lack of funds. CIRM shifted its emphasis to clinical trials. But with the infusion of $5.5 billion from Proposition 14 last fall,the trainingprogram was resurrected.
Directors of the agency are solidly behind what is known as the CIRM Scholars training program. CIRM DirectorDavid Martin, CEO of the biotech companyAvidBiotics, said during last Thursdays meeting that he considered the agencys training programs as the biggest legacy that CIRM will have because of the enduring influence of the young scientists that it is supporting.
Seventeen of 18 training awards went to institutions with links to current or past directors of the agency. All of the organizations that applied received about $5 million each with the exception ofUC Santa Barbarawhich applied for only $1.9 million. A $12 million clinical trial award was made to a Stanford researcher.
In slightly more than 47 minutes, the directors last Thursday rubber-stamped the earlier de facto decisions on the $98 million in grant applications made by anonymous reviewers who met in private. The reviewers also do not have to publicly disclose their financial, professional or personal conflicts of interest.
CIRM board members, however, are required to disclose the outlines of their financial interests. They are not allowed to vote on applications for which they have a legal, financial conflict of interest. Nor do board members, at their award ratification meetings, see the full applications. Only reviewers and CIRM staff have access to those.
(For a look at the process used by directors, see this piece:What is a California ARS? And How Can It Give Away Billions of Dollars?)
Summaries of the reviews are prepared by the staff, however, and often contain illuminating details. The application with the highest score 98 came fromUC Irvine.Peter Donovan at the Orange County campusprepared the application and heads the program. Reviewers were effusive: An excellent proposal in every way almost perfect.
The review summary said,
They have used their experience with prior CIRM training support and (federal)NIH T32 supportto provide meaningful direction to guide the current program. This includes: a focus on mentorship as a key pillar of training; a focus on soft skills in the education of trainees (communication, conflict resolution, management, and skills development); and active involvement of clinical colleagues; a focus on translational research; and increased community engagement and outreach.
(All of the review summaries can be found here.The names of the institutions and personal applicants are not on the summaries. Search them using the application numbers found below.)
One of the recipients has never received major funding from CIRM: theLundquist Instituteof Torrance, Ca., which says14 companies have spun off from research that it has helped to support over the last 12 years.
The clinical trial research awardwent toMaria Grazia Roncaroloof Stanford. (Her review summary can befound here.) The award represents CIRMs 76th clinical tria and involves a potential treatment for a form of pediatric cancer.
Here is the list of CIRM Scholar Training Program awards with the application numbers following the name of the recipient.
Clive Svendsen, EDUC4-12751,Cedars-Sinai,CIRM Training Program in Translational Regenerative Medicine
Prue Talbot, EDUC4-12752,UC Riverside,TRANSCEND Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity
William Lowry, EDUC4-12753,UCLA,UCLA Training Program in Stem Cell Biology
Gage DeKoeyer Crump, EDUC4-12756,University of Southern California,Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine
Camilla Forsberg,EDUC4-12759,UC Santa Cruz,CIRM Training Program in Systems Biology of Stem Cells
Bruce Conklin, EDUC4-12766,Gladstone Institute,CIRM Regenerative Medicine Research Training Program
Michael Barish, EDUC4-12772,City of Hope,Research Training Program in Stem Cell Biology and Regenerative Medicine
Michael Longaker, EDUC4-12782,Stanford,CIRM Scholar Training Program
Dick Hockemeyer, EDUC4-12790,UC Berkeley,Training the Next Generation of Biologists and Engineers for Regenerative Medicine
Jan Nolta, EDUC4-12792,UC Davis,CIRM Cell and Gene Therapy Training Program 2.0
Ching-Ling Lien, EDUC4-12802,Childrens Hospital of Los Angeles,CIRM Training Program for Stem Cell and Regenerative Medicine Research
Alysson Muotri, EDUC4-12804,UC San Diego,Interdisciplinary Stem Cell Training Grant at UCSD III
Peter Schultz, EDUC4-1281,Scripps Research Institute,Training Scholars in Regenerative Medicine and Stem Cell Research
Robert Blelloch, EDUC4-12812,UC San Francisco,Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research
Evan Snyder, EDUC4-12813,Sanford Burnham,A Multidisciplinary Stem Cell Training Program at Sanford Burnham Prebys Institute, A Critical Component of the La Jolla Mesa Educational Network
Dennis Clegg, EDUC4-12821,UC Santa Barbara,CIRM Training Program in Stem Cell Biology and Engineering
Peter Donovan, EDUC4-12822,UC Irvine,CIRM Scholars Comprehensive Research Training Program
Virender Rehan, EDUC4-12837,Lundquist Institute for Biomedical Innovation,Stem Cell Training Program at the Lundquist Institute
Here is a link tothe CIRM news releaseabout the awards.Editors Note: David Jensen is a retired newsman who has covered the state stem cell agency since it was approved by voters in 2004.
Want to see more stories like this? Sign up for The Roundup, the free daily newsletter about California politics from the editors of Capitol Weekly. Stay up to date on the news you need to know.
Sign up below, then look for a confirmation email in your inbox.
Read the original:
- COVID-19: Researchers warn against overhyping early-stage therapies - Medical News Today - October 26th, 2021
- OpRegen Data Update to Be Featured at 2021 American Academy of Ophthalmology Annual Meeting in Presentation by Michael S. Ip, M.D. - Yahoo Finance - October 26th, 2021
- Insights & Outcomes: Place cells, planarians, and 'prewet' proteins - Yale News - October 26th, 2021
- IMAC Holdings The Back Space Announces the Completion of Two Additional Retail Spinal Care Locations - Yahoo Finance - October 26th, 2021
- JEFFERSON PARISH PARTNERS WITH LOUISIANA DEPARTMENT OF HEALTH TO ADMINISTER FREE FLU SHOTS AND COVID-19 VACCINES ON NOVEMBER 6, 2021 - 10-25-YYYY -... - October 26th, 2021
- Male Infertility Could Be Treated With Monkey Cells; New Study Shows How These Animals Could Help Address the Condition - Science Times - October 26th, 2021
- Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters in CLABSI Patients - Yahoo... - October 26th, 2021
- New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia - News-Medical.Net - October 25th, 2021
- Getting to Know Kate Roth at Beacon Integrative Medical Center in Rexburg - East Idaho News - October 25th, 2021
- Global Cell Therapy Market Report 2021-2028 - Growing Adoption of Regenerative Medicine & Introduction of Novel Platforms and Technologies -... - October 25th, 2021
- Vertex reports positive results for first patient in Type 1 diabetes trial - BetaBoston - October 23rd, 2021
- Morris receives grant for stem cell research - The Source - Washington University Record - October 23rd, 2021
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes - PMLiVE - October 23rd, 2021
- McLaughlin Research Institute receives $5 million gift to support neurology studies - Great Falls Tribune - October 23rd, 2021
- AML medication and treatment: What to know - Medical News Today - October 23rd, 2021
- U S Stem Cell : USRM to Focus on Animal Health and Lead Pet-Care Innovation - Marketscreener.com - October 19th, 2021
- Opinion: Why Colin Powell's death should not be framed as the death of a vaccinated person - Poynter - October 19th, 2021
- Quris combines AI with patient on a chip to speed drug development and reduce animal testing - TechCrunch - October 19th, 2021
- Dr. Helen Heslop elected to the National Academy of Medicine - Baylor College of Medicine News - October 19th, 2021
- Researchers report long-lasting effects of gene therapy in children with deadly immune disorder - News-Medical.Net - October 19th, 2021
- Coronavirus: How does misinformation spread, and how can we stop it? - The Jerusalem Post - October 17th, 2021
- Dr. Kahl on the Potential Utility of Frontline CAR T-Cell Therapy in MCL - OncLive - October 17th, 2021
- FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer - Business Wire - October 17th, 2021
- Global Stem Cell and Primary Cell Culture Medium Market 2021 Trends and Leading Players Analysis 2027 Merck, STEMCELL Technologies, Irvinesci, Cell... - October 15th, 2021
- Dr. Erba on the Evolution of Treatment in MCL - OncLive - October 15th, 2021
- After no stem cell donors stepped up to saved her son, mom continues to help others facing the same challenge - Chicago Tribune - October 15th, 2021
- International ZIM Network: SmartMed - Regenerative Solutions for the Therapies of Tomorrow - Business Wire - October 15th, 2021
- Are 'robot massages' the future of muscle repair? - Medical News Today - October 15th, 2021
- What the FDA Panel's Moderna Booster Shot Vote Means and What's Next - NBC Chicago - October 15th, 2021
- Phase 2 Clinical Trial Data of NurOwn in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in... - October 15th, 2021
- R3 Stem Cell & Exosome Therapy: Joint & Back Pain, Avoid ... - October 13th, 2021
- Stem Cell PhD Program | Institute for Stem Cell Biology ... - October 13th, 2021
- New stem cell identified by Sanford Burnham Prebys researchers offers hope to people with rare liver disease - Newswise - October 13th, 2021
- Repurposed Drug Reverses Signs of Alzheimers in Mice, Human Cells - The Scientist - October 13th, 2021
- Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development - StreetInsider.com - October 13th, 2021
- What the latest COVID research says about breakthrough cases and transmission : Shots - Health News - NPR - October 13th, 2021
- HNF collaborates with Rarebase on a Drug Discovery Platform to develop treatments for Charcot-Marie-Tooth (CMT) - PRNewswire - October 13th, 2021
- Autologous HSCT Continues to Show Sustained Benefit in MCL, But Targeted Therapies May Challenge its Role as Standard Frontline Treatment -... - October 13th, 2021
- Bartolo Coln, Winner Of The Cy Young, Wins Lawsuit In Case Of Stem Cell Treatment To Which He Was Subjected Before His Return To The Major Leagues. -... - October 11th, 2021
- The Impact Of Market Restrictions On The US Stem Cell Biomaterials Market - Med Device Online - October 11th, 2021
- Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Letter. - Yahoo Finance - October 11th, 2021
- Top US Leukemia Experts from Academia, Industry and Public Sector Coming Together at Acute Myeloid Leukemia Conference on October 22 - OncLive - October 11th, 2021
- Precision medicine data dive shows water pill may be viable to test as Alzheimer's treatment - National Institutes of Health - October 11th, 2021
- Treating Early Relapse in Follicular Lymphoma - Targeted Oncology - October 11th, 2021
- Humans and Chimpanzees Use a Part of Their DNA in Different Ways - Technology Networks - October 11th, 2021
- A stem cell treatment for MS offers some patients hope. But is it hope that will last? - WHYY - October 9th, 2021
- CAR T Offer New Treatment Option for Non-Hodgkin Lymphoma - Targeted Oncology - October 9th, 2021
- FDA Advisory Committee Recommends Maribavir to Treat Cytomegalovirus CMV Infection and Disease - Contagionlive.com - October 9th, 2021
- What surgeons are saying about regenerative medicine in 2021 - Becker's Orthopedic & Spine - October 9th, 2021
- Study illuminates how BRD4 protein directs the spatial organization of DNA within cell nucleus - News-Medical.net - October 9th, 2021
- Cellular Therapy Strategies Offer the Prospect of Deep Remissions for Multiple Myeloma - OncLive - October 9th, 2021
- Anti-CD47 Therapy and Other New Approaches to the Treatment of Myelodysplastic - Targeted Oncology - October 9th, 2021
- ViaCyte to Present at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa - PRNewswire - October 7th, 2021
- Seattle Stem Cell Therapy Clinic - Seattle Sports Medicine ... - October 7th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - PRNewswire - October 7th, 2021
- New Stem Cell Approach Through Using Wavelength Laser Might have Discovered Why Humans Lose Hair - Tech Times - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - WMTV - NBC15 - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Northwesterns SPORE has made advances in understanding the genetic basis of glioblastoma - News-Medical.Net - October 5th, 2021
- NextCure Announces New Appointments to its Board of Directors - GlobeNewswire - October 5th, 2021
- Therapy and Prevention Strategies for Myocardial Infarction | IJN - Dove Medical Press - October 3rd, 2021
- Lack of awareness about blood stem cell donation is one of the leading causes for low number of donors in In.. - ETHealthworld.com - October 3rd, 2021
- Advanced technique offers new insights about the dynamics of gliomas - News-Medical.net - October 3rd, 2021
- "Stem cell-based therapeutics poised to become mainstream option - BSA bureau - October 2nd, 2021
- The stem cell revolution isnt what you think it is - New Scientist News - October 2nd, 2021
- Researching the Safety and Effectiveness of Stem Cells to Treat 'Long Covid' - Entrepreneur - October 2nd, 2021
- United States Regenerative Medicine Markets to 2026: Focus on Cell Therapies, Gene Therapies, Progenitor & Stem Cell Therapies, Tissue Engineered... - October 2nd, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 2nd, 2021
- Omeros Provides Regulatory Update on Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA - Business Wire - October 2nd, 2021
- Stem Cell Umbilical Cord Blood Market in North America 2021 Sees Growth Due to Rising Spending Capacity and Suitable Payment Plans - PRNewswire - October 2nd, 2021
- BrainStorm to Present Phase 2 Progressive MS Study Results in Oral Presentation at 37th Congress of ECTRIMS - BioSpace - October 2nd, 2021
- Macomics Announces New Hires that Expands its Macrophage-based Drug Discovery R&D Team - BioSpace - October 2nd, 2021
- Stanford neuroscientist's 'assembloids' pave the way for innovative brain research - Scope - October 2nd, 2021
- At the crossroads of reproductive and regenerative medicine: new opportunities for preserving and restoring fertility - ESHRE - September 25th, 2021
- Doctors Debate: Do CAR T Cells and Transplantation Both Have a Place in Aggressive B-Cell Lymphoma Treatment? - Targeted Oncology - September 25th, 2021
- Global Stem Cell Alopecia Treatment Market 2021 Development Status,Industry Insights and Forecast Research Report 2027 Stillwater Current -... - September 25th, 2021
- AML vs. ALL: Differences in symptoms, diagnosis, and survival - Medical News Today - September 25th, 2021
- New gene therapies may soon treat dozens of rare diseases - American Society for Biochemistry and Molecular Biology - September 25th, 2021
- BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program - GlobeNewswire - September 25th, 2021
- Shifts Away From R-CHOP Treatment Shows Improved EFS and OS Benefit in MCL - Targeted Oncology - September 25th, 2021